Tearsheet

SS Innovations International (SSII)

Market Price (10/31/2025): $7.91 | Market Cap: $1.5 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

SS Innovations International (SSII)

Market Price (10/31/2025): $7.91
Market Cap: $1.5 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 158%	Weak multi-year price returns 2Y Excs Rtn is -84%	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -9.5 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -26%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -57%		Stock price has recently run up significantly 12M Rtn12 month market price return is 103%
2			Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -56%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -62%
3			Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.9%
4			High stock price volatility Vol 12M is 139%

0	Strong revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 158%
1	Valuation becoming less expensive P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -57%
2	Weak multi-year price returns 2Y Excs Rtn is -84%
3	Not profitable at operating income level Op Inc LTMOperating Income, Last Twelve Months is -9.5 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -26%
4	Stock price has recently run up significantly 12M Rtn12 month market price return is 103%
5	Not cash flow generative CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -56%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -62%
6	Yield minus risk free rate is negative ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -4.9%
7	High stock price volatility Vol 12M is 139%

Market Valuation & Key Metrics

Valuation
Key Metrics

	10/31/25	2024	2023	2022	2021
Share Price CYE	$7.91	$7.89	$7.25
Market Cap CYE ($ Bil)	1.5	1.4	1.2	-	-
Total Debt ($ Bil)	0.0	0.0	0.0	0.0	0.0
Total Cash ($ Bil)	0.0	0.0	0.0	0.0	0.0
Enterprise Value ($ Bil)	1.5	1.4	1.2
Valuation Ratios
P/S TTM	42.5	65.3	178.8	0.0	0.0
P/EBIT TTM	-184.2	-74.2	-52.6	0.0	0.0
P/E TTM	-132.2	-70.4	-50.3	0.0	0.0
Sector Ratios
P/S TTM (Sector)	4.0	3.5	4.0	4.5	7.3
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4	-1.3	-2.7
P/E TTM (Sector)	-2.0	-1.5	-1.5	-1.3	-2.8

	10/31/25	2024	2023
Share Price CYE	$7.91	$7.89	$7.25
Market Cap CYE ($ Bil)	1.5	1.4	1.2
Total Debt ($ Bil)	0.0	0.0	0.0
Total Cash ($ Bil)	0.0	0.0	0.0
Enterprise Value ($ Bil)	1.5	1.4	1.2
Valuation Ratios
P/S TTM	42.5	65.3	178.8
P/EBIT TTM	-184.2	-74.2	-52.6
P/E TTM	-132.2	-70.4	-50.3
Sector Ratios
P/S TTM (Sector)	4.0	3.5	4.0
P/EBIT TTM (Sector)	-1.6	-1.3	-1.4
P/E TTM (Sector)	-2.0	-1.5	-1.5

	SSII	S&P 500
REVENUE GROWTH	VERY GOOD
Rev LTM ($ Bil)	0.0
Rev Chg Q	192.5%	6.5%
Rev Chg LTM	158.4%	5.4%
Rev Chg 3Y Avg	410.3%	5.3%
PROFITABILITY	VERY POOR
Op Inc LTM ($ Bil)	-0.0
CFO LTM ($ Bil)	-0.0
Net Inc LTM ($ Bil)	-0.0
Op Mgn LTM	-26.3%	18.7%
CFO/Rev LTM	-56.2%	20.3%
Net Inc Mgn	-32.1%	12.7%
VALUATION	VERY HIGH
P/S	42.5	3.2
P/CFO	-75.5	15.3
P/FCF	-68.5	20.3
P/E	-132.2	23.6
STABILITY	GOOD
Debt/Equity	0.01	0.21
Cash/Assets	0.08	0.07

SSII Stock

Return (1M):

Factor Drivers of Stock Movement

The 19.7% change in SSII stock from 7/31/2025 to 10/30/2025 was primarily driven by a 63.0% change in the company's Total Revenues ($ Mil).

	7312025	10302025	Change
Stock Price ($)	6.79	8.13	19.73%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	22.13	36.07	62.96%
P/S Multiple	54.87	43.64	-20.46%
Shares Outstanding (Mil)	178.84	193.59	-8.25%
Cumulative Contribution			18.92%

LTM = Last Twelve Months as of date shown

The -24.8% change in SSII stock from 5/1/2025 to 10/30/2025 was primarily driven by a -51.3% change in the company's P/S Multiple.

	5012025	10302025	Change
Stock Price ($)	10.80	8.13	-24.76%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	20.65	36.07	74.66%
P/S Multiple	89.55	43.64	-51.27%
Shares Outstanding (Mil)	171.14	193.59	-13.12%
Cumulative Contribution			-26.05%

LTM = Last Twelve Months as of date shown

The 103.3% change in SSII stock from 10/30/2024 to 10/30/2025 was primarily driven by a 206.7% change in the company's Total Revenues ($ Mil).

	10302024	10302025	Change
Stock Price ($)	4.00	8.13	103.25%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	11.76	36.07	206.68%
P/S Multiple	58.07	43.64	-24.86%
Shares Outstanding (Mil)	170.74	193.59	-13.38%
Cumulative Contribution			99.61%

LTM = Last Twelve Months as of date shown

null

null

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
SSII Return	-	-	-	-	9%	3%	24%
Peers Return	42%	3%	-9%	-5%	-14%	-18%	-12%
S&P 500 Return	16%	27%	-19%	24%	23%	16%	110%
Monthly Win Rates [3]
SSII Win Rate	-	-	-	29%	42%	67%
Peers Win Rate	40%	33%	32%	28%	42%	47%
S&P 500 Win Rate	58%	75%	42%	67%	75%	67%
Max Drawdowns [4]
SSII Max Drawdown	-	-	-	-	-96%	-59%
Peers Max Drawdown	-25%	-12%	-25%	-25%	-21%	-44%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: A, ATEC, CERS, BDMD, PTHL.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 10/30/2025 (YTD)

How Low Can It Go

SSII has limited trading history. Below is the Health Care sector ETF (XLV) in its place.

Unique Key	Event	XLV	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-16.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	19.1%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	599 days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-28.8%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	40.4%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	116 days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-15.8%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	18.8%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	326 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-40.6%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	68.3%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	1100 days	1480 days

Compare to

In The Past

SPDR Select Sector Fund's stock fell -16.1% during the 2022 Inflation Shock from a high on 4/8/2022. A -16.1% loss requires a 19.1% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About SS Innovations International (SSII)

Business Description

AVRA Medical Robotics, Inc. develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc. and changed its name to AVRA Medical Robotics, Inc. in November 2015. AVRA Medical Robotics, Inc. was founded in 2015 and is based in Orlando, Florida.

Better Bets than SS Innovations International (SSII)

	SSII	Better Performance than SSII
Metric	Value	Industry (Life Sciences Tools & Services)
Rev Chg LTM	158.4%	DCTH (491.3%), IMDX (316.1%), XAIR (168.2%)
Rev Chg 3Y Avg	410.3%	BIAF (10647.3%)
Op Mgn LTM	-26.3%	TMO (18.2%), DHR (19.0%), A (21.3%), IQV (14.2%), MTD (28.4%)
CFO/Rev LTM	-56.2%	TMO (17.5%), DHR (26.0%), A (22.0%), IQV (17.6%), MTD (24.6%)
FCF/Rev LTM	-62.0%	TMO (14.3%), DHR (20.7%), A (16.0%), IQV (13.9%), MTD (21.9%)
Total Yield	-0.7%	TMO (3.1%), DHR (2.3%), A (3.7%), IQV (3.5%), MTD (2.9%)

	SSII	Better Performance than SSII
Metric	Value	Sector (Health Care)
Rev Chg LTM	158.4%	MDGL (3422.0%), CYTK (2635.7%), ARWR (2816.2%), NAMS (762.1%), PRAX (338.5%)
Rev Chg 3Y Avg	410.3%	BBIO (727.6%), CYTK (824.6%), AXSM (699.5%), ARWR (908.8%), TGTX (539.4%)
Op Mgn LTM	-26.3%	LLY (43.0%), JNJ (26.2%), ABBV (23.5%), UNH (6.1%), ABT (17.6%)
CFO/Rev LTM	-56.2%	LLY (20.5%), JNJ (26.3%), ABBV (33.1%), UNH (4.8%), ABT (20.8%)
FCF/Rev LTM	-62.0%	LLY (-0.1%), JNJ (20.3%), ABBV (31.3%), UNH (4.0%), ABT (15.8%)
Total Yield	-0.7%	LLY (2.5%), JNJ (8.2%), ABBV (3.7%), UNH (8.1%), ABT (8.3%)

	SSII	Better Performance than SSII
Metric	Value	All Other Sectors
Rev Chg LTM	158.4%	NBIS (542.6%), CRDO (175.8%), ALAB (163.8%), EXE (169.1%), SW (163.8%)
Rev Chg 3Y Avg	410.3%	QXO (1115.2%), UEC (10082.6%), ENVX (436.9%), PFLT (12481.5%), URG (7785.9%)
Op Mgn LTM	-26.3%	NVDA (58.1%), AAPL (31.9%), MSFT (46.3%), GOOGL (32.2%), AMZN (11.4%)
CFO/Rev LTM	-56.2%	NVDA (46.6%), AAPL (26.6%), MSFT (50.0%), GOOGL (39.3%), AMZN (18.1%)
FCF/Rev LTM	-62.0%	NVDA (43.6%), AAPL (23.5%), MSFT (26.6%), GOOGL (19.1%), AMZN (2.0%)
Total Yield	-0.7%	NVDA (1.8%), AAPL (2.8%), MSFT (3.3%), GOOGL (3.9%), AMZN (3.0%)

		Best Bets In Health Care Sector
	SSII	RPRX	HALO	CPRX	BMY	LNTH	PBH	BIIB	PFE	EW	ILMN
What You Pay
P/E	-135.9	15.3	14.1	12.3	15.4	14.0	14.0	13.6	12.8	11.8	12.4
P/EBIT	-189.3	8.1	11.0	10.5	9.3	9.6	9.0	10.1	10.3	29.2	10.3
What You Get
Rev Chg Q	192.5%	7.7%	40.8%	19.4%	2.8%	-4.1%	-6.6%	2.8%	10.3%	11.9%	-4.8%
Rev Chg LTM	158.4%	3.0%	35.0%	28.5%	1.3%	5.7%	0.6%	4.8%	13.5%	9.1%	-3.3%
Rev Chg 3Y Avg	410.3%	0.8%	35.5%	49.9%	1.0%	34.3%	0.8%	-0.9%	-12.4%	3.0%	-3.0%
FCF/Rev 3Y Avg	-140.0%	113.4%	43.4%	38.9%	29.0%	26.1%	21.6%	17.0%	13.8%	11.9%	9.0%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	SS Innovations International Stock Jumped 12% in a Day, What Now?	Return
2	SS Innovations International (SSII) Debt Comparison	Financials
3	SS Innovations International (SSII) Revenue Comparison	Financials
4	SS Innovations International (SSII) Tax Expense Comparison	Financials
5	SS Innovations International (SSII) Operating Income Comparison	Financials
6	SS Innovations International (SSII) Operating Cash Flow Comparison	Financials
7	SS Innovations International (SSII) EBITDA Comparison	Financials
8	SS Innovations International (SSII) Net Income Comparison	Financials
9	Why SS Innovations International Stock Moved: SSII Stock Has Gained 19% Since 2023 Fiscal End, Primarily Due To Favorable Change In Revenues
10	SS Innovations International (SSII) Valuation Ratios Comparison	Financials
11	ARTICLES
12	Market Movers \| Winners: OPEN, UI, ACMR \| Losers: SPRY, BJ, SSII		August 22nd, 2025
13	Market Movers \| Winners: SSII, BLND, TYRA \| Losers: COTY, NVAX, HOV		August 21st, 2025
14	Market Movers \| Winners: LVWR, IOVA, AVXL \| Losers: SSII, GHRS, KSS		July 24th, 2025
15	Market Movers \| Winners: RGTI, SSII, JOBY \| Losers: MMSI, SEDG, NUTX		July 17th, 2025

	Title
0	DASHBOARDS
1	Market Movers \| Winners: OPEN, UI, ACMR \| Losers: SPRY, BJ, SSII
2	Market Movers \| Winners: SSII, BLND, TYRA \| Losers: COTY, NVAX, HOV
3	Market Movers \| Winners: LVWR, IOVA, AVXL \| Losers: SSII, GHRS, KSS
4	Market Movers \| Winners: RGTI, SSII, JOBY \| Losers: MMSI, SEDG, NUTX
5	ARTICLES
6	SS Innovations International Stock Jumped 12% in a Day, What Now?
7	SS Innovations International (SSII) Debt Comparison
8	SS Innovations International (SSII) Revenue Comparison
9	SS Innovations International (SSII) Tax Expense Comparison
10	SS Innovations International (SSII) Operating Income Comparison
11	SS Innovations International (SSII) Operating Cash Flow Comparison
12	SS Innovations International (SSII) EBITDA Comparison
13	SS Innovations International (SSII) Net Income Comparison
14	Why SS Innovations International Stock Moved: SSII Stock Has Gained 19% Since 2023 Fiscal End, Primarily Due To Favorable Change In Revenues
15	SS Innovations International (SSII) Valuation Ratios Comparison

Trade Ideas

Select past ideas related to SSII. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	4.2%	4.2%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	16.3%	16.3%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.8%	3.8%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	14.0%	14.0%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	13.5%	13.5%	-8.0%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
ADMA_9302025_Dip_Buyer_ValueBuy	09302025	ADMA	ADMA Biologics	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	4.2%	4.2%	-4.6%
REGN_9302025_Dip_Buyer_ValueBuy	09302025	REGN	Regeneron Pharmaceuticals	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	16.3%	16.3%	-0.8%
HAE_9262025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	09262025	HAE	Haemonetics	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	3.8%	3.8%	-0.1%
WAT_9192025_Monopoly_xInd_xCD_Getting_Cheaper	09192025	WAT	Waters	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	14.0%	14.0%	-4.3%
ISRG_9052025_Monopoly_xInd_xCD_Getting_Cheaper	09052025	ISRG	Intuitive Surgical	Monopoly	MY \| Getting CheaperMonopoly-Like with P/S Decline Large cap with monopoly-like margins or cash flow generation and getting cheaper based on P/S multiple	13.5%	13.5%	-8.0%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

1 Month Top Gainers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PRAX	Praxis Precision Medicines	279.1%	161.2%
2	INBX	Inhibrx Biosciences	131.0%	409.8%
3	PUMP	ProPetro	99.6%	16.2%
4	DYN	Dyne Therapeutics	88.4%	-0.0%
5	VICR	Vicor	85.4%	89.2%
6	CELC	Celcuity	74.6%	503.2%
7	GLUE	Monte Rosa Therapeutics	73.5%	87.5%
8	NVTS	Navitas Semiconductor	72.1%	251.8%
9	LUMN	Lumen Technologies	70.3%	94.7%
10	BALY	Ballys	63.4%	4.1%

1 Month Top Losers

#	Ticker	Company	1M Rtn	YTD Rtn
1	PMI	Picard Medical	-62.9%	5106.3%
2	LRN	Stride	-53.8%	-35.8%
3	FMC	FMC	-51.0%	-66.6%
4	FI	Fiserv	-48.3%	-68.3%
5	NFE	New Fortress Energy	-43.6%	-91.9%
6	VG	Venture Global	-41.7%
7	OGN	Organon	-40.2%	-55.0%
8	VRNS	Varonis Systems	-39.5%	-21.2%
9	ITGR	Integer	-38.5%	-52.2%
10	LENZ	LENZ Therapeutics	-37.9%	5.5%

Recent Active Movers

1 Day Top Gainers

#	Ticker	Company	1D Rtn	YTD Rtn
1	GH	Guardant Health	27.9%	202.5%
2	GCI	Gannett	27.7%	3.8%
3	FORM	FormFactor	24.2%	34.7%
4	VIAV	Viavi Solutions	22.3%	69.3%
5	GSAT	Globalstar	22.2%	63.5%
6	MTSR	Metsera	22.1%	63729900.0%
7	PRM	Perimeter Solutions	21.1%	102.3%
8	CHRW	C.H. Robinson Worldwide	19.7%	52.6%
9	INSM	Insmed	16.3%	181.3%
10	CAH	Cardinal Health	15.4%	62.8%

1 Day Top Losers

#	Ticker	Company	1D Rtn	YTD Rtn
1	FMC	FMC	-46.5%	-66.6%
2	APLS	Apellis Pharmaceuticals	-31.0%	-35.0%
3	THRY	Thryv	-30.2%	-44.8%
4	SFM	Sprouts Farmers Market	-26.1%	-39.2%
5	IART	Integra Lifesciences	-23.5%	-47.9%
6	ITRI	Itron	-21.1%	0.4%
7	WOLF	Wolfspeed	-18.2%
8	CMG	Chipotle Mexican Grill	-18.2%	-46.1%
9	CI	Cigna	-17.4%	-9.2%
10	EME	EMCOR	-16.6%	43.0%

1 Week Top Gainers

#	Ticker	Company	1W Rtn	YTD Rtn
1	INBX	Inhibrx Biosciences	176.8%	409.8%
2	PUMP	ProPetro	71.2%	16.2%
3	RNA	Avidity Biosciences	43.5%	139.6%
4	DYN	Dyne Therapeutics	42.8%	-0.0%
5	GCI	Gannett	39.3%	3.8%
6	FORM	FormFactor	38.3%	34.7%
7	MBX	MBX Biosciences	35.1%	18.2%
8	BBNX	Beta Bionics	33.8%
9	GH	Guardant Health	33.3%	202.5%
10	LUMN	Lumen Technologies	32.7%	94.7%

1 Week Top Losers

#	Ticker	Company	1W Rtn	YTD Rtn
1	PMI	Picard Medical	-75.2%	5106.3%
2	LRN	Stride	-56.1%	-35.8%
3	NTLA	Intellia Therapeutics	-52.6%	5.2%
4	FMC	FMC	-48.7%	-66.6%
5	FI	Fiserv	-47.4%	-68.3%
6	VRNS	Varonis Systems	-43.8%	-21.2%
7	THRY	Thryv	-33.4%	-44.8%
8	NFE	New Fortress Energy	-30.5%	-91.9%
9	AKBA	Akebia Therapeutics	-29.5%	10.5%
10	UAMY	United States Antimony	-28.9%	371.2%

Peer Comparisons for SS Innovations International

Financials

	SSII	A	ATEC	CERS	BDMD	PTHL	Median
Name	SS Innov.	Agilent .	Alphatec	Cerus	Baird Me.	Pheton
Mkt Price	8.13	143.36	16.33	1.40	1.40	0.63	4.77
Mkt Cap	1.6	40.7	2.4	0.3	-	-	2.0
Rev LTM	36	6,788	682	193	-	-	437
Op Inc LTM	-9	1,444	-95	-12	-	-	-11
FCF LTM	-22	1,088	-32	3	-	-	-9
FCF 3Y Avg	-17	1,308	-123	-16	-	-	-16
CFO LTM	-20	1,495	16	6	-	-	11
CFO 3Y Avg	-15	1,662	-45	-13	-	-	-14

Growth & Margins

	SSII	A	ATEC	CERS	BDMD	PTHL	Median
Name	SS Innov.	Agilent .	Alphatec	Cerus	Baird Me.	Pheton
Rev Chg LTM	158.4%	4.5%	26.3%	13.3%	-	-	19.8%
Rev Chg 3Y Avg	410.3%	0.8%	33.0%	7.8%	-	-	20.4%
Rev Chg Q	192.5%	10.1%	27.5%	16.3%	-	-	21.9%
QoQ Delta Rev Chg LTM	30.6%	2.4%	6.2%	4.0%	-	-	5.1%
Op Mgn LTM	-26.3%	21.3%	-13.9%	-6.1%	-	-	-10.0%
Op Mgn 3Y Avg	-134.7%	21.5%	-24.2%	-13.8%	-	-	-19.0%
QoQ Delta Op Mgn LTM	13.0%	-0.1%	4.2%	0.5%	-	-	2.3%
CFO/Rev LTM	-56.2%	22.0%	2.3%	3.0%	-	-	2.6%
CFO/Rev 3Y Avg	-130.1%	24.6%	-9.6%	-8.2%	-	-	-8.9%
FCF/Rev LTM	-62.0%	16.0%	-4.6%	1.8%	-	-	-1.4%
FCF/Rev 3Y Avg	-140.0%	19.4%	-24.6%	-10.2%	-	-	-17.4%

Valuation

	SSII	A	ATEC	CERS	BDMD	PTHL	Median
Name	SS Innov.	Agilent .	Alphatec	Cerus	Baird Me.	Pheton
Mkt Cap	1.6	40.7	2.4	0.3	-	-	2.0
P/S	43.6	6.0	3.6	1.4	-	-	4.8
P/EBIT	-189.3	26.9	-18.6	-26.7	-	-	-22.7
P/E	-135.9	33.4	-14.7	-14.2	-	-	-14.5
P/CFO	-77.6	27.2	156.0	46.9	-	-	37.1
Total Yield	-0.7%	3.7%	-6.8%	-7.0%	-	-	-3.8%
Dividend Yield	0.0%	0.7%	0.0%	0.0%	-	-	0.0%
FCF Yield 3Y Avg	-1.5%	3.7%	-7.3%	-4.2%	-	-	-2.9%
D/E	0.0	0.1	0.2	0.4	-	-	0.2
Net D/E	0.0	0.0	0.2	0.1	-	-	0.1

Returns

	SSII	A	ATEC	CERS	BDMD	PTHL	Median
Name	SS Innov.	Agilent .	Alphatec	Cerus	Baird Me.	Pheton
1M Rtn	25.1%	11.7%	12.3%	-11.9%	-34.0%	-19.5%	-0.1%
3M Rtn	19.7%	25.1%	54.3%	9.4%	-31.4%	-29.6%	14.6%
6M Rtn	-24.8%	35.2%	47.6%	7.7%	-74.8%	-83.7%	-8.5%
12M Rtn	103.3%	9.9%	190.6%	-18.6%	-49.1%	-85.1%	-4.3%
3Y Rtn	-	5.9%	59.5%	-61.7%	-	-	5.9%
1M Excs Rtn	12.9%	1.8%	15.2%	-9.6%	-36.2%	-21.6%	-3.9%
3M Excs Rtn	21.8%	17.2%	9.2%	0.9%	-36.1%	-32.0%	5.0%
6M Excs Rtn	-46.5%	13.5%	25.9%	-14.0%	-96.5%	-105.5%	-30.3%
12M Excs Rtn	86.1%	-7.3%	192.7%	-35.8%	-70.5%	-103.6%	-21.5%
3Y Excs Rtn	-	-67.8%	-18.7%	-137.9%	-	-	-67.8%

Financials

Annual
Quarterly

$ Mil \| FY: 12/31	LTM	2024	2023	2022	2021	2020	2019
Period End	9/30/2025	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019
Filing Date	10/28/2025	4/15/2025	3/22/2024	3/31/2023	11/4/2022	9/6/2022	2/22/2022
Key Financials
Total Revenue	36	21	6	1	0	0	0
EBITDA	-7	-18	-20	-3	-1	-1	-3
Operating Income	-9	-19	-20	-3	-1	-1	-3
Net Income	-12	-19	-21	-3	-1	-1	-3
EPS	-0.06	-0.11	-0.14	-0.03	-0.50	-0.50	-1.60
Growth Rates
Total Revenue Growth	158.4%	251.5%	309.1%	∞%	-	-	-
EBITDA Growth	73.8%	10.5%	-595.4%	-94.6%	-34.9%	67.4%	-253.8%
Operating Income Growth	67.6%	6.4%	-585.3%	-110.3%	-27.6%	66.8%	-246.0%
Net Income Growth	60.6%	8.3%	-549.6%	-116.5%	-32.0%	66.8%	-252.6%
Margins
EBITDA Margin	-20.5%	-85.9%	-337.5%	-198.6%	-	-	-
Operating Income Margin	-26.3%	-91.9%	-345.1%	-206.0%	-	-	-
Net Income Margin	-32.1%	-92.7%	-355.4%	-223.8%	-	-	-
Cash & Debt
Total Cash	6	0	2	0	0	0	0
Total Debt	13	18	9	8	0	0	0
Net Debt / (Cash)	7	18	7	8	-0	0	0
Cash Flows
Net Cash from Operations	-20	-10	-15	-6	-0	-0	-0
Free Cash from Operations	-22	-10	-16	-6	-0	-0	-0
Returns to Shareholders
Dividends	0	-0	-0	-0	-0	-0	-0
Share Repurchases	-0	-0	-0	-0	0	-0	-0

$ Mil \| FY: 12/31	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	10/28/2025	8/6/2025	5/14/2025	4/15/2025	11/14/2024	9/6/2024	5/15/2024	3/22/2024	11/13/2023	8/7/2023	5/15/2023	3/31/2023
Key Financials Quarterly
Total Revenue	13	10	5	8	4	5	4	1	2	2	0	1
Ebitda	-1	1	-5	-1	-3	-4	-10	-12	-2	-5	-1	-1
Operating Income	-2	0	-6	-2	-3	-4	-10	-12	-2	-5	-1	-1
Net Income	-4	-0	-6	-2	-3	-4	-10	-12	-2	-6	-1	-1
EPS	-0.02	0.00	-0.03	-0.01	-0.02	-0.02	-0.06	-0.08	-0.01	-0.04	-0.01	-0.01
Key Financials TTM
Total Revenue TTM	36	28	22	21	14	12	9	6	5	4	2	1
Ebitda TTM	-7	-9	-13	-18	-28	-27	-28	-20	-9	-7	-3	-2
Operating Income TTM	-9	-11	-15	-19	-29	-28	-29	-20	-9	-8	-3	-2
Net Income TTM	-12	-11	-15	-19	-29	-28	-29	-21	-10	-8	-4	-2
Growth Rates Quarterly
Total Revenue Growth	192.5%	121.8%	40.8%	469.0%	100.6%	138.3%	882.8%	57.3%	313.1%	-	-	-
EBITDA Growth	51.5%	115.1%	46.8%	87.6%	-66.8%	25.7%	-834.9%	-1311.0%	-332.4%	-655.3%	-1210.0%	-141.7%
Operating Income Growth	42.7%	102.4%	39.8%	84.9%	-73.0%	21.0%	-818.4%	-1286.5%	-335.4%	-616.0%	-1230.7%	-217.3%
Net Income Growth	-14.6%	93.8%	42.3%	84.2%	-70.9%	25.1%	-649.6%	-1080.9%	-290.3%	-634.6%	-1532.7%	-190.7%
Margins Quarterly
EBITDA Margin	-10.9%	5.7%	-99.5%	-18.3%	-65.6%	-84.4%	-263.1%	-838.3%	-78.9%	-270.9%	-276.6%	-93.5%
Operating Income Margin	-14.3%	1.0%	-115.6%	-22.7%	-73.1%	-90.9%	-270.3%	-852.5%	-84.7%	-274.4%	-289.3%	-96.7%
Net Income Margin	-29.0%	-2.6%	-111.0%	-23.7%	-74.0%	-91.8%	-270.5%	-851.3%	-86.8%	-292.0%	-354.8%	-113.4%
Cash & Debt
Total Cash	6	11	16	0	0	1	1	2	7	0	0	0
Total Debt	13	10	10	18	15	15	11	9	6	6	5	8
Net Debt / (Cash)	7	-2	-5	18	15	13	10	7	-0	6	5	8
Cash Flows Quarterly
FCF from Operations	-7	-3	-6	-3	-3	-1	-3	-4	-6	-3	-2	-3
Cash Flows TTM
FCF from Operations TTM	-20	-15	-13	-10	-11	-14	-16	-15	-14	-10	-8	-6
Returns to Shareholders Quarterly
Dividends	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	-7.3%	0.4%	-28.0%	-9.8%	-18.0%	-26.3%	-63.9%	-94.5%	-20.4%	-80.8%	-24.3%	-39.0%
Return on Invested Capital (ROIC) TTM
ROIC TTM	-9.5%	-12.1%	-17.8%	-25.3%	-41.2%	-44.9%	-47.2%	-39.4%	-24.7%	-29.4%	-17.6%	-23.4%

Price Behavior

Price Behavior

Market Price	$8.13
Market Cap ($ Bil)	1.6
Distance from 52W High	-28.4%
	50 Days	200 Days
DMA Price	$5.24	$6.95
DMA Trend	up	up
Distance from DMA	55.3%	17.0%
	3M	1YR
Volatility	113.5%	148.8%
Downside Capture	-70.33	-47.26
Upside Capture	41.40	38.22
Correlation (SPY)	6.1%	-0.4%

SSII Betas & Captures as of 9/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	2.50	1.14	0.97	-0.01	-0.00	-3.13
Up Beta	-3.64	-1.83	-4.43	-0.56	-0.66	1.93
Down Beta	-2.32	2.84	0.08	1.00	0.68	-1.00
Up Capture	192%	120%	309%	-32%	31%	-1%
Bmk +ve Days	13	23	35	74	144	420
Stock +ve Days	9	20	30	49	90	186
Down Capture	642%	244%	321%	40%	-23%	3%
Bmk -ve Days	8	19	29	52	107	330
Stock -ve Days	11	20	31	66	88	185

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

Short Interest

Short Interest: As Of Date	10152025
Short Interest: Shares Quantity	159,834
Short Interest: % Change Since 9302025	69.6%
Average Daily Volume	183,907
Days-to-Cover Short Interest	1
Basic Shares Quantity	193,589,845
Short % of Basic Shares	0.1%

Returns Analyses

	Title
0	SS Innovations International Stock Jumped 12% in a Day, What Now?

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
10/28/2025	1.5%
8/7/2025	3.8%	1.0%	8.8%
3/31/2025	6.4%	-3.1%	13.6%
SUMMARY STATS
# Positive	3	1	2
# Negative	0	2	1
Median Positive	3.8%	1.0%	11.2%
Median Negative		-3.1%
Max Positive	6.4%	1.0%	13.6%
Max Negative		-3.1%

	Forward Returns
10/28/2025	1.5%
8/7/2025	3.8%	1.0%	8.8%
3/31/2025	6.4%	-3.1%	13.6%
SUMMARY STATS
# Positive	3	1	2
# Negative	0	2	1
Median Positive	3.8%	1.0%	11.2%
Median Negative		-3.1%
Max Positive	6.4%	1.0%	13.6%
Max Negative		-3.1%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	10282025	10-Q 9/30/2025
6302025	8062025	10-Q 6/30/2025
3312025	5142025	10-Q 3/31/2025
12312024	4152025	10-K 12/31/2024
9302024	11142024	10-Q 9/30/2024
6302024	9062024	10-Q 6/30/2024
3312024	5152024	10-Q 3/31/2024
12312023	3222024	10-K 12/31/2023
9302023	11132023	10-Q 9/30/2023
6302023	8072023	10-Q 6/30/2023
3312023	5152023	10-Q 3/31/2023
12312022	3312023	10-K 12/31/2022
9302022	11302022	10-Q 9/30/2022
6302022	11302022	10-Q 6/30/2022
3312022	11302022	10-Q 3/31/2022
12312021	11042022	10-K 12/31/2021

Insider Activity

Expand for More

	Owner	Title	Filing Date	Action	Price	Shares	Transacted Value	Value of Held Shares	Form
0	Cohen Barry F	COO - Americas	4222025	Buy	8.75	100	875	77,383,950	Form
1	Cohen Barry F	COO - Americas	4162025	Buy	8.93	103	920	78,974,000	Form
2	Cohen Barry F	COO - Americas	4102025	Buy	9.16	500	4,580	81,002,521	Form
3	Cohen Barry F	COO - Americas	4022025	Buy	10.00	100	1,000	88,395,800	Form
4	MOLL FREDERIC H		2242025	Buy	1.37	3,645,224	5,001,247	13,803,435	Form

Industry Resources

Health Care Resources

U.S. National Library of Medicine

Health Data Management

FDA Tracker

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

SS Innovations International (SSII)

Market Price (10/31/2025): $7.91 | Market Cap: $1.5 BilSector: Health Care | Industry: Life Sciences Tools & Services

SS Innovations International (SSII)

Market Price (10/31/2025): $7.91Market Cap: $1.5 BilSector: Health CareIndustry: Life Sciences Tools & Services

Market Valuation & Key Metrics

SSII Stock

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About SS Innovations International (SSII)

Interactive Breakdown

Better Bets than SS Innovations International (SSII)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for SS Innovations International

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (10/31/2025): $7.91 | Market Cap: $1.5 Bil
Sector: Health Care | Industry: Life Sciences Tools & Services

Market Price (10/31/2025): $7.91
Market Cap: $1.5 Bil
Sector: Health Care
Industry: Life Sciences Tools & Services